Business description: Vimian Group AB

Vimian Group AB is a Sweden-based veterinary company. The Company is a parent company of the group of companies operating with a purpose of improving animal health through science and technology. The Group delivers solutions to veterinary professionals, labs and pet parents around the world. The purpose of Vimian Group is to unite companies in selected niches of animal health and help them grow faster. The Company invests in innovation and new technologies to advance veterinary medicine. The Group covers four essential and rapidly evolving areas within animal health: Specialty Pharma, Diagnostics, Veterinary Services and MedTech. Vimian provides individual businesses with access to its networks, advisory services, infrastructure and capital.

Number of employees: 1,300

Sales by Activity: Vimian Group AB

Fiscal Period: December 2021 (EUR) 2022 (EUR) 2023 (EUR) 2024 (EUR) 2025 (EUR)

Specialty Pharma

6.84Cr 12Cr 15Cr 17Cr 18Cr

Medtech

6.19Cr 10Cr 11Cr 12Cr 16Cr

Veterinary Services

1.68Cr 3.44Cr 4.95Cr 5.82Cr 6.45Cr

Diagnostics

2.67Cr 2.31Cr 2.15Cr 2.09Cr 2.29Cr

Eliminations

-5L -18.32L -2L -3L -4L

Geographical breakdown of sales: Vimian Group AB

Fiscal Period: December 2021 (EUR) 2022 (EUR) 2023 (EUR) 2024 (EUR) 2025 (EUR)

USA

5.6Cr 11Cr 12Cr 14Cr 15Cr

Other Countries

5.05Cr 4.64Cr 3.08Cr 4.32Cr 5.44Cr

United Kingdom of Great Britain and Northern Ireland

1.17Cr 3.1Cr 3.79Cr 4.5Cr 5.35Cr

Australia

- - 1.87Cr 2.07Cr 2.7Cr

France

1.19Cr 1.84Cr 1.92Cr 2.24Cr 2.67Cr

Italy

2.31Cr 2.2Cr 2.38Cr 2.39Cr 2.65Cr

Germany

1.37Cr 1.38Cr 1.44Cr 1.7Cr 2.05Cr

Denmark

- 1.32Cr 1.55Cr 1.82Cr 1.98Cr

Sweden

64.3L 1Cr 1.86Cr 1.6Cr 1.71Cr

Netherlands

- 65.19L 79.12L 89L 1.02Cr

Canada

- - 1.26Cr 1.17Cr 99L

New Zealand

- 63.42L 72.78L 74L 73L

Executive Committee: Vimian Group AB

Manager TitleAgeSince
Chief Executive Officer 43 24/11/2025
Chief Executive Officer 47 17/07/2025
Investor Relations Contact 45 01/09/2021
Corporate Officer/Principal 43 13/04/2026
Human Resources Officer 41 01/11/2023

Composition of the Board of Directors: Vimian Group AB

Director TitleAgeSince
Chairman 60 22/05/2024
Director/Board Member 59 01/01/2022
Director/Board Member 63 29/04/2025
Chairman 49 01/01/2021
Director/Board Member 37 01/01/2021

Shareholders: Vimian Group AB

NameStocks%Valuation
Fidelio Capital AB
59.13 %
31,10,22,999 59.13 % 941 M kr
Prg Investment Holdings
3.394 %
1,78,50,843 3.394 % 54 M kr
Grandeur Peak Global Advisors LLC
2.319 %
1,21,98,023 2.319 % 37 M kr
Anicom Gestion
1.901 %
1,00,00,000 1.901 % 30 M kr
Investering & Tryghed AS
1.583 %
83,25,742 1.583 % 25 M kr

Company details: Vimian Group AB

Vimian Group AB

Riddargatan 19

114 57, Stockholm

+

http://www.vimian.com
address Vimian Group AB(VIMIAN)

Group companies: Vimian Group AB

NameCategory and Sector
Vimian FinCo AB

Veterinary Drugs

Change 5-day change 1-year change 3-year change Capi.($)
0.00%+13.06%-19.80%+2.73% 178.35Cr
-0.78%+0.65%-51.73%-53.72% 3.35TCr
-0.25%+2.32%+75.45%+137.32% 1.21TCr
-3.36%-3.93%+1.56%+25.22% 460.5Cr
-1.03%-3.02%+5.97%+16.61% 330.97Cr
-0.80%+4.47%+62.47%+28.16% 201.49Cr
-1.27%+0.35%+33.18%+132.29% 130.94Cr
-1.39%+0.77%-23.01%-8.85% 106.54Cr
-1.77%+2.31%-3.90%-44.68% 102.14Cr
-0.86%-2.55%-2.96%-23.44% 94Cr
Average -1.12%+1.40%+7.72%+21.16% 616.95Cr
Weighted average by Cap. -0.69%+1.40%-11.16%+3.15%
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
2.904EUR
Average target price
3.184EUR
Spread / Average Target
+9.64%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VIMIAN Stock
  4. Company Vimian Group AB
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!